Fetal akinesia syndrome X linked

Fetal Akinesia Syndrome X-Linked (FASXL) is a rare genetic disorder characterized by reduced fetal movement (akinesia), muscle weakness, and developmental abnormalities. This condition falls under the broader category of fetal akinesia deformation sequence (FADS), a group of disorders that can lead to a wide range of physical and developmental challenges due to decreased fetal movement.

Etiology

FASXL is caused by mutations in a specific gene located on the X chromosome. The exact gene implicated can vary, but these mutations disrupt normal muscle development and function, leading to the symptoms associated with the syndrome. As an X-linked disorder, FASXL is more commonly observed in males, who have only one X chromosome, whereas females, with two X chromosomes, may be carriers of the disorder without showing symptoms.

Clinical Presentation

The clinical presentation of FASXL can vary significantly among affected individuals but generally includes:

• Reduced fetal movement: This is often the first sign of FASXL and can be detected during pregnancy through ultrasound.
• Muscle weakness and atrophy: Affected individuals may show signs of muscle weakness at birth or in early infancy.
• Joint deformities: Due to the lack of movement in utero, individuals with FASXL may be born with joint deformities such as clubfoot or hip dislocation.
• Respiratory difficulties: Compromised muscle strength can affect the respiratory muscles, leading to breathing problems.
• Facial and cranial abnormalities: Some individuals may present with facial and cranial abnormalities due to the reduced fetal movement.

Diagnosis

Diagnosis of FASXL involves a combination of clinical evaluation, family history, and genetic testing. Prenatal ultrasound can detect reduced fetal movement and some physical abnormalities. After birth, a detailed physical examination and the observation of symptoms can suggest FASXL, which can then be confirmed through genetic testing to identify the specific X-linked mutation.

Management and Treatment

There is no cure for FASXL, and management focuses on treating the symptoms and improving the quality of life for affected individuals. This may include:

• Physical therapy: To improve muscle strength and joint mobility.
• Respiratory support: Including ventilation support for those with significant respiratory difficulties.
• Surgical interventions: To correct joint deformities or other physical abnormalities.
• Nutritional support: To ensure adequate growth and development.

Prognosis

The prognosis for individuals with FASXL varies widely depending on the severity of symptoms and the presence of associated complications. Early intervention and supportive care can improve outcomes, but some individuals may have significant physical and developmental challenges.

See Also

• Fetal Akinesia Deformation Sequence (FADS)
• Genetic Disorders
• Muscular Dystrophy
• X-Linked Genetic Disorders

Fetal akinesia syndrome X linked Resources
Latest articles Most recent articles Ongoing trials	Wikipedia